Department od anesthesiology, intensive care and pain management
Maribor, 2000, Slovenia
NCT Number: NCT04046861
The aim of our study is to find out whether high doses of vitamin C before cardiopulmonary bypass and during the first 24 hours after that have and impact of lowering the incidence of hyperlactatemia.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Interventional
Not applicable
Maribor, 2000, Slovenia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The vitamin C group will get high dose of intravenous vitamin C (ascorbic acid) before starting cardiopulmonary bypass, before removing aortic clamp and every 8 hours thereafter for additionaly 24 hours
Other names: Vitamin C
The placebo group will get saline before starting cardiopulmonary bypass, before removing aortic clamp and every 8 hours thereafter for additionaly 24 hours
Time frame: up to 30 hours
Measuring the concentration of lactate before cardiopulmonary bypass, after aortic clamp removal, at ICU admission,then every 6 hours
Time frame: up to 36 hours
The need for noradrenaline and other vasopressors (e.g. vasopresin) during the surgery and in the 24-hours after the end of the surgery
Time frame: up to 30 hours
Measuring the concentration of glucose before cardiopulmonary bypass, after aortic clamp removal, at ICU admission, then every 6 hours
University Medical Centre Maribor
Other
"Influence of High Vitamin C Dose on Lactate During Extracorporeal Circulation for Heart Surgery and During the 24 Hours Thereafter." (double Blind Prospective Randomised Study)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05032521
Actue Circulatory Failure, Hyperlactatemia
Dijon, France
View Trial DetailsNCT05505396
Acute Brain Injury, Brain Diseases
Copenhagen, Denmark
View Trial DetailsNCT05145049
Brain Diseases, Brain Neoplasms
Ankara, Turkey (Türkiye)
View Trial DetailsNCT05649358
Hyperlactatemia, Metabolic Diseases
Edmonton, Alberta, Canada
View Trial Details